510(k) Report

510(k) · Cleared

Cleared

Perioglas - Bioglass Bone Graft Particulate

K962494510(k) TraditionalCleared Sep 20, 199686-day reviewClass II21 CFR 872.3930

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Usbiomaterials Corp. · LYC Bone Grafting Material, Synthetic

Cleared on Sep 20, 1996 as substantially equivalent to K952922 (Orthovita Co., 1995) and 1 other predicate after an 86-day review. Its family tree reaches back 1 generation to 1995. 158 later devices descend from it.

Decided
Sep 20, 1996
Review
86 days
Class
Class II
Product code
LYC
Recalls
None
Predicates
2

Its longest line of descent runs back 1 generation to K941780 (1995). 2 ancestors in all. 158 later devices descend from it, 7 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 1995: 1 other ancestor2007: 7 descendants cleared2004: 3 descendants cleared2011: 8 descendants cleared2006: 4 descendants cleared2003: 1 descendant cleared2005: 2 descendants cleared2025: 19 descendants cleared2016: 4 descendants cleared2009: 7 descendants cleared2012: 4 descendants cleared2010: 9 descendants cleared2008: 4 descendants cleared2015: 5 descendants cleared2013: 3 descendants cleared2014: 6 descendants cleared2026: 12 descendants cleared2019: 5 descendants cleared2018: 6 descendants cleared2021: 8 descendants cleared2023: 13 descendants cleared2020: 2 descendants cleared2024: 13 descendants cleared2022: 8 descendants cleared2017: 5 descendants clearedK941780 · Orthovita Biogran · Orthovita Co. · 19951995200020052010201520202025
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor 1 generation forward: 7 descendants2 generations forward: 14 descendants3 generations forward: 30 descendants4 generations forward: 34 descendants5 generations forward: 32 descendants6 generations forward: 13 descendants7 generations forward: 15 descendants8 generations forward: 9 descendants9 generations forward: 3 descendants10 generations forward: 1 descendant K941780 · Orthovita Biogran · Orthovita Co. · 19950+5+10
  1. Root · 1 generation backK941780 Orthovita BiogranOrthovita Co. · 1995
  2. This deviceK962494 Perioglas - Bioglass Bone Graft ParticulateUsbiomaterials Corp. · 1996
  3. Descendant · cites it directly · 85 of its ownK033994 Novabone-BBG-Resorbable Bone Graft SubstituteNovabone Products, LLC · 2004
  4. Descendant · 2 generations on · 84 of its ownK041613 Novabone - AR - Resorbable Bone Graft SubstituteNovabone Products, LLC · 2004
  5. Descendant · cites it directly · 80 of its ownK040278 Perioglas-Bioglass Bone Graft SubstituteNovabone Products, LLC · 2004
  6. Descendant · 3 generations on · 59 of its ownK082672 Novabone Putty-Bioactive Synthetic Bone GraftNovabone Products, LLC · 2008
  7. Descendant · 4 generations on · 47 of its ownK101860 Novabone Putty- Bioactive Synthetic Bone GraftNovabone Products, LLC · 2010

Showing 5 of 158 descendants. See all descendants

Descendants cleared per year

2003: 12004: 32005: 22006: 42007: 72008: 42009: 72010: 92011: 82012: 42013: 32014: 62015: 52016: 42017: 52018: 62019: 52020: 22021: 82022: 82023: 132024: 132025: 192026: 12
2003high 19 (2025) · low 1 (2003)2026

Most influential descendants

Showing 5 of 158 · See all
  • K033994Novabone-BBG-Resorbable Bone Graft SubstituteNovabone Products, LLC · 2004 · cites it directly85descendants
  • K041613Novabone - AR - Resorbable Bone Graft SubstituteNovabone Products, LLC · 2004 · 2 generations on84descendants
  • K040278Perioglas-Bioglass Bone Graft SubstituteNovabone Products, LLC · 2004 · cites it directly80descendants
  • K082672Novabone Putty-Bioactive Synthetic Bone GraftNovabone Products, LLC · 2008 · 3 generations on59descendants
  • K101860Novabone Putty- Bioactive Synthetic Bone GraftNovabone Products, LLC · 2010 · 4 generations on47descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K941780Orthovita BiogranOrthovita Co.1995—
0 (this device)K962494Perioglas - Bioglass Bone Graft ParticulateUsbiomaterials Corp.1996—
+1K033994Novabone-BBG-Resorbable Bone Graft SubstituteNovabone Products, LLC2004—
+2K041613Novabone - AR - Resorbable Bone Graft SubstituteNovabone Products, LLC2004—
+1K040278Perioglas-Bioglass Bone Graft SubstituteNovabone Products, LLC2004—
+3K082672Novabone Putty-Bioactive Synthetic Bone GraftNovabone Products, LLC2008—
+4K101860Novabone Putty- Bioactive Synthetic Bone GraftNovabone Products, LLC2010—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199510

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200310
200430
200520
200640
200770
200840
200970
201090
201180
201240
201330
201460
201550
201640
201750
201860
201950
202020
202180
202280
2023130
2024130
2025190
2026120
FIG. 1 — Lineage of K962494, 1995–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LYC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LYC device

  1. #1 K253317 Cytrans™ Elashieldscore 14.3 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (5)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K952922Biogran Bioactive Glass Synthetic Bone Graft Material
Summary page 1
…nd ridge augmentation based upon additional clinical data and determination of substantial equivalence to the legally marketed device Orthovita- Biogran™ (Ref. [510(k)]# K952922, K941780). To confirm safety and efficacy, a recently completed human clinical study in extraction sites demonstrated favorable…
Orthovita Co.1995—
*K941780Orthovita Biogran
Summary page 1
…augmentation based upon additional clinical data and determination of substantial equivalence to the legally marketed device Orthovita- Biogran™ (Ref. [510(k)]# K952922, K941780). To confirm safety and efficacy, a recently completed human clinical study in extraction sites demonstrated favorable results f…
Orthovita Co.1995—
*—Hapset™
Named without a submission number
—
*—Osteogen®
Named without a submission number
—
*—Periograf®
Named without a submission number
—

Also cleared against K952922: 3 other devices →

What descends from it? (158)

See all 158

7 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K033994Novabone-BBG-Resorbable Bone Graft SubstituteNovabone Products, LLC200485
K040278Perioglas-Bioglass Bone Graft SubstituteNovabone Products, LLC200480
K053387Perioglas Bone Graft ParticulateNovabone Products, LLC200613
K063596Perioglas Putty-Bioactive Bone Graft GelNovabone Products, LLC20074
K063549Novabone Dental Putty-Bioactive Synthetic Bone GraftNovabone Products, LLC20072
K031073Perioglas Plus - Settable Bone Graft SubstituteNovabone Products, LLC20031
K112428Novabone Dental Morsels - Bioactive Synthetic Bone GraftNovabone Products, LLC20110

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • None of the 2 ancestors has a recall.
  • Of its descendants, K033994 (Novabone Products, LLC, 2004) has gone furthest, with 85 descendants of its own.
  • 3 other devices also cite its predicate K952922.

How does its category compare?

All LYC devices

LYC Bone Grafting Material, Synthetic: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LYC

3in 2025

2007: 132008: 82009: 142010: 132011: 92012: 52013: 22014: 12016: 22020: 32022: 22025: 32026 (partial year): 3
2007high 14 (2009) · low 0 (2015)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LYC

267in 2025

2007: 80 days median2008: 73 days median2009: 100 days median2010: 164 days median2011: 224 days median2012: 120 days median2020: 156 days median2025: 267 days median2026 (partial year): 266 days median
2007high 267 (2025) · low 73 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LYC

1in 2018

2009: 12010: 22012: 22016: 22018: 1
2007high 2 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LYC

2in 2025

2007: 232008: 252009: 252010: 282011: 212012: 102013: 122014: 92015: 142016: 1402017: 192018: 142019: 152020: 52021: 122022: 62023: 92024: 62025: 2
2007high 140 (2016) · low 2 (2025)2025

MAUDE reports naming product code LYC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071380023
2008873025
200914100125
201013164228
20119224021
20125120210
20132—012
20141—09
20150—014
20162—2140
20170—019
20180—114
20190—015
2020315605
20210—012
20222—06
20230—09
20240—06
2025326702
202632660—

What is it indicated for?

Perioglaso is indicated for use in infraboney pockets caused by periodontal disease.

The intended uses have been extended to extraction sites and ridge augmentation

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K962494: Perioglas - Bioglass Bone Graft Particulate.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K962494

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026